Pretreatment with Haloperidol Reduces123I-FP-CIT Binding to the Dopamine Transporter in the Rat Striatum: An In Vivo Imaging Study with a Dedicated Small-Animal SPECT Camera

Authors:
  • CAChristina Antke
    Christina Antke
  • KKKonstantin Kley
    Konstantin Kley
  • MBMarkus Beu
    Markus Beu
  • AWAndreas Wirrwar
    Andreas Wirrwar
  • HMHans-Wilhelm Müller
    Hans-Wilhelm Müller

Abstract
Synaptic dopamine is mainly regulated by presynaptic dopamine transporter (DAT) activity. We hypothesized that variations in synaptic dopamine are reflected by variations of DAT radioligand binding. The effect of haloperidol, which increases synaptic dopamine concentrations, was therefore assessed in the rat striatum using 123I-N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl)-nortropane (123I-FP-CIT) as a DAT radioligand. Methods: Striatal 123I-FP-CIT binding was measured in 24 rats under baseline conditions (no pretreatment) and at 1 h after injection of haloperidol or a vehicle (1 mg/kg) using a small-animal SPECT camera. Results: Baseline equilibrium ratios (V3″) were 1.32 ± 0.24 (mean ± SD). After the haloperidol injection, V3″ decreased to 0.99 ± 0.38 (P2-tailed < 0.0001), corresponding to a mean reduction of DAT binding by 25%. Conclusion: Our results are indicative of competition between the DAT ligand 123I-FP-CIT and synaptic dopamine elevated by haloperidol, suggesting that the assessment of 123I-FP-CIT binding may be suitable to study variations in synaptic dopamine in vivo.

This publication has 35 references indexed in Scilit: